FBN1 and FBN2 genes were included in the list of potential markers due to their demonstrated role in AIS pathogenesis [39] and the reduced level of their expression found in AIS compared to control donors [29], compatible with epigenetic regulation. The gene discussed is FBN2; the disease is androgen insensitivity syndrome.